Menu
Back to Journals » Drug Design, Development and Therapy » Volume 16
Original Research
Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,262 | Dovepress* | 4,129+ | 238 | 4,367 | |
| PubMed Central* | 133 | 84 | 217 | ||
| Totals | 4,262 | 322 | 4,584 | ||
| *Since 27 June 2022 | |||||
View citations on PubMed Central and Google Scholar